The 3rd Biobased Chemicals Commercialization &
Partnering Conference is Scheduled for 2012!
Click
here! |
|
|
|
| |
|
Day 1 - Thursday, July 7, 2011 |
| |
|
| 7:00 |
Registration & Continental Breakfast |
| | |
| 7:55 |
Welcome & Opening Remarks |
| |
David T. Quinby, Partner, Stoel Rives
LLP |
| | |
|
Session I |
|
Creating Market Pull for Biobased Chemicals |
|
Moderator: David T. Quinby, Stoel Rives LLP |
| | |
| 8:10 |
Sustainable Drop-Ins: Product Pull through
Competitive Economics and Differentiated Performance |
| |
Steve del Cardayre, Vice President, Research & Development, LS9 |
| | |
| | LS9 has
developed a platform technology for the sustainable production of a diversity of
fuels and chemicals. The heart of the technology lies in the selectivity and
efficiency of our engineered microbial catalysts and the simple cost-effective
processes they enable. LS9 has initially focused on the production of existing
products for which established and growing markets exist. The LS9 platform
enables market pull through competitive pricing, feedstock and supplier
alternatives, and sustainability. The LS9 technology in addition enables the
tailoring of molecule structure and performance at a level not previously
possible, which allows for the production of differentiated products with
enhanced performance and economic benefits. |
| | |
| 8:35 |
Priming the Pump –
Preparing the Supply Chain for Bio-BDO |
| |
Damien Perriman, Vice President, Business
Development, Genomatica |
| | |
| |
A presentation on the application validation steps for building market
acceptance and excitement for a biobased product. The presentation will cover
Genomatica’s scale up results for Bio-BDO and discuss details of the recently
announced collaboration with Tate & Lyle for demonstration scale production.
Balancing the demands for sample material from numerous prospects will be
contrasted with production volumes during scale up. Issues like material quality
and pricing will also be discussed, particularly on the light of 1st
to market opportunities. |
| | |
| 9:00 |
Commercialization of
Javelin Technology: From Lab to Retail Shelf |
| |
Cora Leibig, Vice President, Research and
Development, Segetis |
| | |
| |
JavelinTM Technology from Segetis is a new-to-the-world biobased
chemical platform. Segetis is actively commercializing solvents and plasticizers
based on the technology in applications ranging from household cleaners to
paints to construction vinyl. Commercialization has required success on many
fronts including product development, regulatory approval, process development
and scale-up, and supply-chain development.
Benefits:
- Description of how to develop and position new-to-the-world products on market
- Description of markets most receptive to “green” or “bio-based” value prop
- Scale-up strategies which minimize capital expenditure
- Partnership development |
| | |
| 9:25 |
USDA BioPreferredSM
Program “Double Your Market Advantage” |
| |
Rudy Pruszko, Business and Industry Field
Specialist, Center for Industrial Research and Service (CIRAS) |
| | |
| |
The presentation will provide a brief background of the BioPreferredSM
Program and the new USDA Labeling Program. It will answer the question “What is
the BioPreferred Program” and discuss the Federal Procurement Preference
Program, labeling initiative and future issues associated with the programs. The
benefits of attending the presentation is gaining knowledge about the various
programs, how to improve the marketing of your products, how to obtain a USDA
Certified Label, and what the future holds for the program. |
| | |
| 9:50 |
Networking & Refreshment Break |
| | |
|
Session II |
|
Industry Update: New Technologies and Platforms Influencing Biobased Chemical
Production |
|
Moderator: David T. Quinby, Stoel Rives LLP |
| | |
| 10:20 |
Transforming
Industrial Biotechnology |
| |
Johan van Walsem, Vice President of Strategy
and Commercial Development, Metabolix |
| | |
| |
Metabolix is a bioscience company and pioneer in the development of biobased
plastics and chemicals using bio-renewable feedstocks. The company develops
innovative solutions by combining its expertise in industrial biotechnology
(multi-gene systems, microbial engineering and plant biotechnology) with
engineering excellence (systems integration and pilot manufacturing) to address
global markets. Metabolix applies its expertise in Polyhydroxyalkanoate (PHA)
chemistry to two primary pathways: fermentation and industrial crop development.
The first commercial platform from our fermentation pathway is Mirel
Bioplastics. Mirel provides product and packaging options that can respond to
the strong societal and market drivers for transitioning from petroleum to
biobased solutions.
During this presentation, we will discuss our fermentation based portfolio of
products including Mirel, our bioplastic commercialized through a Joint Venture
with Archer Daniels Midland. Metabolix has also created a fermentation pathway
for C4 chemical development. Our years of experience in fermentation leads to an
accelerated development pathway to commercialization for this new product
portfolio. The company is in the pre-commerical stages of developing specialty
C4 (pyrrolidone derivatives) chemicals. These products offer very robust
economics based on our advantaged process. This presentation will cover the
scale-up activities for the first C4 chemicals as well as the industrial
chemicals to follow (BDO and acrylates). These second generation chemicals have
an addressable market over $10
ion and the company’s transformational technologies and scalability will
result in lower costs for these products. Our presentation will also cover the
global nature of these developing technologies and the potential commercial
markets they could positively impact. |
| | |
| 10:45 |
Moving Bio-Based
Resins through the Value Chain for Green Buildings |
| |
Joe Fox, Director, Emerging & External
Technologies, Ashland |
| | |
| |
This presentation will describe the value chain for commercializing a family of
new, bio-based building products using resin intermediates made with
biorenewable raw materials. The resin intermediates are unsaturated polyester
resins that have been made using soybean oil, corn-derived ethanol and/or other
chemical building blocks obtained from biomass. The building products include
countertops, tubs and showers, and restaurant furniture. Efforts to increase
awareness of these products at GreenBuild and via the new website
www.compositebuild.com will be described.
Benefits:
• Learn about the value chain for green building materials and where Ashland
participates in this chain.
• Learn about the chemistry of Ashland’s bio-based EnvirezTM resins.
• See examples of commercial building products made with bio-based composite
resins and adhesives.
• Learn about the recently-launched website:
www.compositebuild.com
|
| | |
| 11:10 |
Opportunities and
Challenges for a New Foundation for Bio-based Chemicals |
| |
Peter Keeling, Director of Innovation &
Industry Collaboration, Center for Biorenewable Chemicals (CBiRC) |
| | |
| |
CBiRC is developing the tools, components and materials needed to transform
carbohydrate feedstocks into bio-based chemicals. Core knowhow and technologies
include bioengineering of fatty acid and polyketide biochemistry in
microorganisms, as well as an innovative and complimentary portfolio of
developments in chemical catalysis. By combining biocatalysis and chemical
catalysis CBiRC creates new knowhow and powerful technologies that have the
potential to nurture a sustainable bio-based chemical industry. CBiRC believes
the existing petrochemical supply chain can be transformed with key foundational
intermediates that deliver an array of drop-in chemistry or similar
functionality to existing fossil-carbon-based chemicals. Here we will describe
our progress towards creating a new foundation for bio-based chemicals.
|
| | |
| 11:35 |
Biofuels &
Biochemicals Production in a Biorefinery |
| |
Manoj Kumar, Director Science & Technology,
Global New Business Development, DSM Bio-Based Products and Services |
| | |
| |
DSM brings a sustainable operational history and an industry leading skill-set
in the field of Industrial Biotechnology to the challenge of Biorefining. We are
leveraging the longstanding competencies and knowledge derived from the
biotechnology, chemistry, and operational components of DSM.
In this presentation, we will describe our work and success achieved for
sustainable biorefining for making biochemicals and advanced biofuels based upon
full integration of all operational and technology elements that has been
developed concurrently within powerful industry partnerships.
We will provide data to illustrate that today’s business model for the supply of
bioproducts software into the Bioethanol/biofuels/Bio-based chemicals and
materials market sector will not be sustainable for the future, whereby such
products will need to be manufactured within the boundaries of the Biorefinery
itself. Biomass saccharifying cellulase enzymes cocktails manufacturing will
have to be fully integrated into such a Biorefinery or it could be connected as
a “on site” or “bolt-on” facility. Additional key elements of integration will
include, amongst others, co-development and deployment of suitable fermentation
organisms that are capable to metabolize mixed sugars simultaneously along with
effective pre-treatment technologies that generate hydrolysates and or
hydrolysable substrates.
We will illustrate that the above focus on integration and the ability to impact
all relevant process technologies will create, through compelling economics, a
strong sustainable advantage for Biorefinery practitioners on a global basis.
Benefits:
1. Better understanding of sustainability requirement of our world to deliver
products and services for both current and future needs.
2. With Petroleum at $100/barrel and peak output has reached, biomass and
biorefineries are the only option left for producing renewable liquid fuel for
transportation and sugars for making chemicals.
|
| | |
| 12:00 |
Renewable Products
for Industrial Applications |
| |
Laura Martin, Commercial Development Manager,
POET |
| |
The specialty chemical industry, which is primarily based on petroleum based
products, generates $860 billion in annual economic activity worldwide. There
are many renewable products manufactured from emerging biorefineries that can
replace those products. New ethanol co-products can help ethanol plants become
true biorefineries, unlocking the additional potential of each kernel of corn.
Cellulosic biorefineries can also provide new opportunities since diverse
feedstock leads to new products. This presentation will highlight renewable
specialty chemicals produced from POET biorefineries for food and industrial
applications. |
| | |
| 12:25 |
Lunch On Your Own |
| | |
|
Session II |
|
Industry Update: New Technologies and Platforms Influencing Biobased Chemical
Production (Cont.) |
|
Moderator: David T. Quinby, Stoel Rives LLP |
| | |
| 2:00 |
Systems Biology and
Novel Culturing System for Bio-Based Chemicals from Cyanobacteria |
| |
F. Blaine Metting, Biological & Environmental
Sciences Product Line Manger, Battelle Memorial Institute, Pacific Northwest
National Laboratory |
| | |
| |
Systems biology research at PNNL focuses on nitrogen-fixing cyanobacteria
(blue-green algae) in an effort to improve existing understanding of bio-fuels
and bio-products production by a using a metabolic modeling approach for
simulating the fundamental metabolic and regulatory controls in these organisms.
The research addresses the potential for production of high value compounds as
well as bio-hydrogen and other fuels based on metabolic engineering. The
research has also resulted in novel, proprietary dual culture systems for
cost-effective production of fuels and products from industrial waste streams
and sunlight. Variations of the co-culture approach will be described for
selected fuels and products. |
| |
|
| 2:25 |
Chemicals and
Biofuels from Underutilized Biomass Feedstocks: Biorefinery Strategies for the
West |
| |
William J. Orts, Research Leader, Bioproduct
Chemistry & Engineering, USDA - ARS - WRRC |
| | |
| 2:50 |
Farnesene:
Applications for a Bio-Renewable Feedstock |
| |
Adam Safir, Director, Polymer Science,
Amyris Biotechnologies |
| | |
| 3:15 |
Overcoming Feedstock Challenges for Biochemical Production |
| |
Gregory Boholmann, Director of Business
Development,
Genencor/Danisco |
| | |
| 3:40 |
Networking & Refreshment Break |
| | |
| 4:10 |
Production of
Biofuels/Biochemicals from Non-Food Based Biomass by the RITE bioprocess |
| |
Hideaki Yukawa, Director, Molecular
Microbiology and Biotechnology Group, RITE-Research Institute of Innovative
Technology for the earth |
| | |
| |
In order to combat global warming and find alternatives to the increasingly
scarce fossil fuel resources, the world’s attention is focused on renewable
biomass as the most sustainable resource for future biofuel and commodity
chemicals. At RITE, we developed the "RITE bioprocess" to utilize “soft biomass”
to produce biofuels and chemicals. This talk highlights our experiences in
developing our bioprocess.
- The U.S. set a valuable example for the rest of the world to emulate;
developing new technologies based on the biorefinery concept must be a strongly
promoted national policy. It resulted in a significant increase in U.S.
production of bio-ethanol, the representative product of the biorefinery
concept, over a short time span.
- Most current biofuel production processes utilize food crops, and bio-ethanol
production was inevitably blamed for recent high food prices. There is,
therefore, a persistent need to shift to "soft-biomass", obtained from non-food
crops as well as inedible parts of food crops, as the demand for the biofuels
will only increase. Our bioprocess adapts well to disparate substrates.
- The RITE bioprocess utilizes Corynebacterium glutamicum, which is already
widely used in industrial production of amino acids. The bioprocess is, however,
based on a new concept that fundamentally resolves many of the technological
problems of conventional bioprocesses. It is very versatile in the range of
products possible.
- To demonstrate this versatility, ethanologenic C. glutamicum strains densely
packed in a reactor under growth-arrested conditions enabled high volumetric
productivity of various chemicals. Cells were able to utilize mixed sugar
substrates derived from lignocellulosic biomass. |
| | |
|
Session III |
|
The Financial Future of Biobased Chemicals: Securing Funding and Strategic
Partnerships |
|
Moderator: David T. Quinby, Stoel Rives LLP |
| | |
| 4:35 |
The Role of
Intellectual Property in Securing Funding and Strategic Partnerships |
| |
Gladys Monroy, Senior Partner, Morrison &
Foerster |
| | |
| 5:00 |
Leveraging the Value
Chain of Partnerships for Bio-based Chemicals |
| |
Dan Verser, Executive VP of Research &
Development and Founder, ZeaChem
Inc. |
| | |
| |
ZeaChem is a producer of economical and sustainable advanced biofuels and
bio-based chemicals. Using a variety of feedstock resources, ZeaChem is
developing multiple product platforms as alternatives to petroleum-based
products.
Successfully bringing bio-based chemicals to market requires many partners along
the value chain. The first key to success is feedstock supply. ZeaChem is
working with GreenWood Resources (GWR), the nation’s leader in hybrid poplar
tree management, as the primary feedstock provider for ZeaChem’s demonstration
scale biorefinery and first commercial production facility. In addition, local
agricultural residues will supply supplemental feedstock.
Second, ZeaChem is using known processes and equipment from well respected
industry vendors including KMPS and Sulzer. The process components are
integrated in a novel way, significantly reducing scale-up and financing risk of
biorefinery facilities.
Third, off-take partners will bring ZeaChem’s products to market. ZeaChem has
off-take agreements in place from its demonstration scale facility and is
developing agreements for its first commercial biorefinery.
Forth, financial, product development and market pull through partners play a
vital role in commercializing bio-based chemicals. ZeaChem is developing
relationships in all of these areas to accelerate commercialization of its
bio-based chemical platforms.
Benefits:
1. Explore the value chain of partnerships needed to bring bio-based chemicals
to market.
2. Understand the unique role for each type of partner.
3. Discuss how the integration of these partners will successfully commercialize
bio-based chemicals. |
| | |
| 5:30 |
Networking Reception |
| | |
| |
Poster Abstract |
| |
Richa Tungal, Department of Chemical and
Biological Engineering, South Dakota School of Mines & Technology |
| | |
|
|
| | |
|
Day 2 - Friday, July 8, 2011 |
| | |
| 7:30 |
Continental Breakfast |
| | |
|
Session III |
|
The Financial Future of Biobased Chemicals: Securing Funding and Strategic
Partnerships (Cont.) |
| | |
| 8:25 |
Panel Discussion |
| |
Panel Moderator: David T. Quinby, Partner, Stoel Rives LLP |
| |
Panelists: |
| |
Doug Cameron,Founder and Managing Director, Alberti Advisors,
LLC |
| |
Cora Leibig, Vice President, Research and Development,Segetis |
| |
Damien Perriman, Vice President, Business Development, Genomatica |
| |
Ajay Kshatriya, Head of Commercial, Bio Architecture Lab Inc. |
| | |
|
Session IV |
|
Biobased Chemical Challenges – Lab to Commercial Scale Up |
|
Moderator: Barbara Balos
Bowker |
| | |
| 9:10 |
Launching the
Bio-PDO™ Platform – The Sorona® Story |
| |
Ray W. Miller, Global Business Development
Manager, BioMaterials and Specialties, DuPont Applied BioSciences |
| | |
| |
DuPont is rapidly evolving from a 200+ year old chemicals and materials company
to an industrial biotechnology powerhouse. Ray will briefly explain the driving
forces behind this transformation and outline DuPont’s approach to the
development and commercialization of sustainable materials and energy offerings.
He will focus heavily on the development and commercial introduction of the
Sorona® polymer business, and the subsequent development of bio-sourced 1,3
propanediol (Bio-PDO?) as well as progress being made to broaden the offerings
of value-added specialties based on this initial platform molecule. The
presentation will explain the necessity of understanding the markets and what
they require to be able to create market pull for new materials vs. incumbents
from petroleum sources. Ray will conclude with some suggestions on the role of
governments in helping businesses achieve a fundamental shift away from
petroleum dependency in our materials and fuels industries.
Members of the audience will learn:
- motivations for bio-based fuels and chemicals
- how to establish a market for materials that are not a “drop-in”
- how to persevere when the going gets tough
- how governmental policy can influence success |
| | |
| 9:35 |
Developing the
Biorefineries of the Future |
| |
Mark Warner, Senior Vice President, Process
Industries, Harris Group (Seattle) |
| | |
| |
There are various technical pathways that can be used for converting forest
residuals and other biomass into bio-based chemicals and liquid transportation
fuels. This presentation will review the technical and economic advantages of
the most promising technologies, along with the pathways for scaling up to
commercial production. This session will provide a unique perspective on
scale-up, performance guarantees and financing considerations.
• Understanding of commercially available technologies of making bio-based
chemicals.
• Unique perspective of mix of technical and economic perspectives.
• Perspective of industry leaders currently involved in commercialization of
multiple biomass conversion technologies.
• Experience with biomass, algae, sugars, municipal solid waste and most
commonly available biomass sources. |
| | |
| 10:00 |
Networking & Refreshment Break |
| | |
| 10:40 |
Myriant’s Path to
Succinic Acid Commercialization |
| |
Samuel G. McConnell, Senior Vice President,
Corporate Development, Myriant Technologies, Inc. |
| | |
| |
In the past year Myriant Technologies has announced two deals that have
accelerated the company’s commercial bio-based Succinic Acid (SAC) program. PTT,
with an investment of $60 million, provides capital to the world’s first bio
based SAC plant under construction by Myriant in Lake Providence, LA. In
addition, Davy and Myriant, through an exclusive partnership, will develop and
offer bio-based Butanediol (BDO). Davy is the world’s premier BDO licensor and
has over 1 billion lbs of production capacity installed globally. Davy will now
offer Myriant’s SAC as a feedstock for existing and future BDO plants in
addition to developing an integrated sugar to BDO process by integrating the
Myriant SAC process with the Davy BDO process.
Myriant’s SAC plant in Lake Provide is currently under construction with the
support of PTT and a $50 million grant by the Department of Energy (DOE). The
plant is slated to be completed the second half of 2012, and will have a
production capacity of 30 million lbs/year.
In addition to the Davy market channel, Myriant has also concluded several
contracts for the purchase of SAC from customers in the plasticizer, urethane
and solvent markets.
Myriant will present the company’s critical next steps in the commercialization
of bio SAC and the company’s over-all commercial SAC strategy. In addition, the
company will describe opportunities, pit falls and lessons learned on the road
to commercializing SAC. |
| | |
|
Session IV |
|
Advanced Biofuels: Developments, Sustainability and Commercialization |
|
Moderator: Barbara Balos
Bowker |
| | |
| 11:05 |
Designer
Triglyceride Oils and Renewable Chemicals |
| |
Walter Rakitsky, VP Strategy & Emerging
Businesses, Solazyme |
| | |
| |
Solazyme has developed a unique and proprietary industry-leading microbial
chemicals platform which exploits designer triglyceride oils as the basis for
the next generation of high performance bio-based fluids and green chemicals.
Solazyme’s core technology utilizes microalgae to transform carbohydrate
feedstocks into fatty acids in the triglyceride form. These triglyceride oils
can then be converted through biological or chemical routes to numerous
value-added chemicals, such as surfactants, lubricants and polymers in existing
industry infrastructure. Properties of the designer oils are manipulated to
increase their value over existing renewable oils by optimizing chain length
distribution and levels of saturation. Solazyme’s industrial fermentation
manufacturing platform allows production of thousands of tons of designer oils
from multiple carbohydrate feedstocks and thus can be deployed worldwide. In
this presentation, we will discuss how and why Solazyme’s renewable chemicals
platform expands the possibilities for further replacements of petroleum derived
oils with renewable, sustainable alternatives.
|
| | |
| 11:30 |
Replacing
Petrochemical Aromatics with BioFormPXTM and Other Bio-Based
Alternatives |
| |
Kieran Furlong, Commercial Manager, Virent
Energy Systems |
| | |
| |
The interest in and demand for alternative sources of aromatic chemical
intermediates have significantly increased in recent years for a number of
reasons. Consumers, major retailers and non-governmental organizations have all
called for more sustainable packaging and materials. Consumer brand companies
see marketing potential in “greener” packaging. Manufacturers have suffered
increased volatility and rising costs due to crude oil pricing. Many of the
polymers widely used in consumer packaging and products are produced from
aromatic intermediates (polyester from paraxylene; polystyrene from benzene;
etc). All of this has directed focus towards bio-based alternatives. Virent has
successfully demonstrated the production of biobased paraxylene, which – when
combined with existing bio-MEG – enables a fully bio-based, renewable,
recyclable PET/polyester polymer. This presentation will describe Virent’s novel
BioFormPX™ including the production process, and how other aromatics chemicals
and fuels are produced using the same technology.
Members of the audience will learn
- how this technology allows the production of the first 100% bio-based PET
bottle or polyester fiber
- how similar the bio-based paraxylene is to the conventional petro-based
material
- how the production of bio-based chemicals interacts with the production of
fuel in a bio-refinery
- the economic parameters for the commercialization of bio-based PX
|
| | |
| 12:00 |
Lunch
provided by GTC |
| | |
| | |
| 2:30 |
Conference Concludes |
| | |
|
|
 |
Attend ALL 2011 GTCbio Conferences for
only $3995 industry rate or $1990 acad/govt rate.
Click
here to sign up! |